Sponsored By

Bergen International doubles its manufacturing and production capabilities

Bergen International has a new 45,000 sq-ft building facility that includes a new extrusion line complete with updated material handling equipment. The new building also houses a laboratory facility. In addition, Bergen has increased its production, laboratory, shipping and receiving staff.

PlasticsToday Staff

October 22, 2014

1 Min Read
Bergen International doubles its manufacturing and production capabilities

"We are very pleased to add this new facility and increase our production capacity," said Bergen CFO Richard Long. "This new facility, combined with additional shipping and receiving personnel, will ensure that we are able to meet the increased demand for our Foamazol, Foamazol XO, and Foamazol XOP chemical foaming agent products. This will also allow us to better service new markets for these CFAs. The addition of new laboratory staff and facilities allows us to have a greater ability to develop custom products for our customers, and to tailor existing products to specific customer applications. As we approach the end of our 15th anniversary in business, Bergen looks forward to continuing our focus exclusively on the manufacture of chemical foaming agents for the plastics industry."  

Bergen International's Foamazol, Foamazol XO, and Foamazol XOP chemical foaming agents are available for use in most plastic applications such as pipe, profile and sheet extrusion; injection, structural foam, and rotational molding; blown and extruded films; wire and cable extrusion; blow molded containers; polypropylene ribbon extrusion and others. These CFAs are available in endothermic, exothermic and endo/exo blends. Forms include pelletized masterbatches and powders. Products are available for use with a range of resins such as PP, PE, copolymers, PS, PPO, and PPE, PET, TPO/TPE and thermoplastic rubber. Custom formulations are also available. 

Sign up for the PlasticsToday NewsFeed newsletter.

You May Also Like